top of page

The BCAL Board

Jayne Shaw.jpeg

Jayne Shaw

Executive Chair

Trained as a Registered Nurse in the UK, on arrival in Australia she became a Director of Nursing and Chief Executive Officer of two private hospitals. Following this she established an Australian and International  consulting business which was sold to Healthsouth a large US Healthcare company. After  this she became the Co-founder of Vision Group an Opthalmic Doctor equity consolidation model which was successfully listed on the ASX.

Jayne joined a number of private Healthcare Boards involved with specialist consolidation including Cardiology, Orthopaedics, and Women’s Health she continued to work with Private Equity firms on local and International Healthcare transactions. Jayne, together with Ron Phillips was a co-owner of Sydney Breast Clinic and a co-founder of BCAL Diagnostics. Current Board positions are Critical Group – Heatley’s Industrial Supplies, The Woolcock Research Institute, and The Hareda Foundation established to invest in Women’s Health Initiatives.

Ron Phillips.jpg

The Hon Ron Philips (AO)

Non-Executive Director

Following 15 years in the NSW Parliament which included serving as Minister for Health and Deputy Leader of the Opposition, Ron developed a successful consulting business in the Health and Aged Care Industry.

His business interests included co-owner and Managing Director of Sydney Breast Clinic which he sold to Healthscope. He currently serves as Chair of the Sydney Local Health District and as Director on Westmead IVF.


Jonathan Trollip

Independent Non-Executive Director

Jonathan is a globally experienced independent director with over 30 years commercial, corporate, governance and legal and transactional expertise. Jonathan is currently non-executive independent chairman of ASX listed Global Value Fund Ltd, Spheria Emerging Companies Ltd and Plato Income Maximizer Limited. He is a non-executive director of ASX listed Kore Potash Limited and holds private company directorships in the commercial and not-for-profit sectors.

Jonathan was a principal of Sydney, Australia based structured finance group Meridian International Capital Limited for over 20 years, Prior to that, Jonathan was a partner with law firm Herbert Smith Freehills. Jonathan currently has a New South Wales Law Society Practicing Certificate and is a Fellow of the Australian Institute of Company Directors.


Merilyn Sleigh

Independent Non-Executive Director

Dr. Sleigh has over 30 years of experience as a senior executive and non-executive director in Australia’s biotechnology sector. She was, from its foundation, Chief Executive Officer and Managing Director of EvoGenix Limited, a biotech startup company that expanded internationally and listed on the ASX before acquisition by a larger company.

She was formerly Dean of the Faculty of Life Sciences, University of NSW; Director of Research & Development at Australian biotech Peptech Ltd and a research scientist and senior manager with CSIRO. She has held non-executive director positions with Mimetica Pty Ltd and Adalta Ltd as well as with ASX listed companies Clover Corporation, and Tyrian Diagnostics Ltd.

Other director roles have been with government and not-for-profit organisations, including the Rural Industries Research and Development Corporation and Relationships Australia. She has acted as an adviser and consultant to companies, government, research institutes and investors on technology commercialisation. She holds a BSc, Doctorate in Philosophy and Diploma in Corporate Management and is a Fellow of the Australian Institute of Company Directors.


Mark Burrows AO

Independent Non-Executive Director

Mark Burrows AO will be joining the BCAL Board on a pro-bono basis, as he is an advocate for early diagnosis of breast cancer and other cancers. He has enjoyed a long and distinguished career in investment banking both in Australia and the UK. Mark co-founded Baring Brothers Burrows & Co in Australia in the early 80s. In 1999 he was appointed the Managing Director/ Deputy Chairman of ING Barings in London. In 2004, Mark joined Lazard as a Managing Partner and in 2006 returned to Australia and was appointed Lazard Australia’s inaugural Chairman. Mark returned to investment banking in 2011 as Vice Chairman of Credit Suisse’s Global Investment Bank.

During his extensive investment banking career, Mark has been the principal financial advisor to some of the most significant and transformative corporate and government transactions in Australia. Mark has served as a non-executive director on several Australasian and UK public companies including Chairman and Deputy Chair of Brambles, Fairfax Media and Telstra.

Since the Rio Earth Summit in 1992, Mark has also been an advocate of global financial institutions’ Private Sector involvement in sustainable development. Over this period, Mark has retained a number of roles advising United Nations, G20 and corporates on climate initiatives relating to the financial sector. From 2017 to 2020, Mark was a Senior Advisor to Macquarie Bank, on climate finance and renewable energy. Mark currently retains a role as a senior advisor to UNEP, UNDP, The Green Finance Initiative in London and is on the Asian Council of The Nature Conservancy. He is also a Senior Advisor to the G20 Sustainability Group.

bottom of page